ClinicalTrials.Veeva

Menu

Unmasking Concealed Arrhythmia Syndromes (UCAS)

Imperial College London logo

Imperial College London

Status

Enrolling

Conditions

Brugada Syndrome (BrS)
Brugada ECG Patterns

Treatments

Diagnostic Test: Continuous long term ambulatory ECG monitoring
Diagnostic Test: 12-lead ECG
Diagnostic Test: Ultra-high-frequency ECG

Study type

Observational

Funder types

Other

Identifiers

NCT06988189
REC 24/NS/0032

Details and patient eligibility

About

This study seeks to evaluate whether using non-invasive electrocardiograph (ECG) techniques, including long term ECG monitoring with wearable ECGs, can improve the detection of concealed Brugada syndrome.

Full description

Application of long term continuous ECG monitoring via ECG wearables and ambulatory ECG monitors to detect manifestations of Brugada syndrome. This approach will be combined with development of an AI (artificial intelligence) enabled ECG platform to automate Brugada ECG detection and analysis.

The protocol will comprise the following parts:

Study A: Brugada ECG AI development. This will automate the recognition of the type 1 Brugada ECG pattern on 12 lead ECGs.

Study B: Remote arrhythmia diagnostics. A prospective observational study whereby recruited participants will be fitted with a wearable ECG or cardiac monitor to undergo continuous long term ambulatory ECG monitoring. The algorithms developed in study A will be applied to long term ECG data captured in this study.

Study C: Arrhythmic risk stratification using ultra-high-frequency ECG. This exploratory study will look for markers of arrhythmic risk in patients with manifest and concealed arrhythmia syndromes.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults willing to take part
  • Able to give consent

Exclusion criteria

  • Unable to give consent
  • Children age < 18 years and adults > 100 years old

Trial design

200 participants in 3 patient groups

Healthy volunteers
Description:
Volunteer participants with no cardiac structural or arrhythmic conditions.
Treatment:
Diagnostic Test: Ultra-high-frequency ECG
Diagnostic Test: 12-lead ECG
Diagnostic Test: Continuous long term ambulatory ECG monitoring
Manifest Arrhythmia Syndrome
Description:
Manifest arrhythmia syndrome patients (patients with an arrhythmic syndrome with an abnormal ECG)
Treatment:
Diagnostic Test: Ultra-high-frequency ECG
Diagnostic Test: 12-lead ECG
Diagnostic Test: Continuous long term ambulatory ECG monitoring
Concealed Arrhythmia Syndrome
Description:
Concealed arrhythmia syndrome patients (patients with a normal ECG with a known underlying arrhythmic diagnosis)
Treatment:
Diagnostic Test: Ultra-high-frequency ECG
Diagnostic Test: 12-lead ECG
Diagnostic Test: Continuous long term ambulatory ECG monitoring

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Ahran Arnold, PhD; Keenan Saleh, MBBS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems